Viewing Study NCT03376503


Ignite Creation Date: 2025-12-24 @ 7:44 PM
Ignite Modification Date: 2026-02-24 @ 5:08 AM
Study NCT ID: NCT03376503
Status: COMPLETED
Last Update Posted: 2017-12-19
First Post: 2017-12-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Nanogen Pegfilgrastim (Pegcyte) PK/PD Clinical Study in Breast Cancer Patients
Sponsor: Nanogen Pharmaceutical Biotechnology Joint Stock Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module